Bristol Myers Squibb BMY has strengthened its near-term outlook following robust fourth-quarter 2025 results reported on Feb. 5, 2026. The stock rose 7.6% post-earnings, closing at $61.99 on Feb. 6 — ...
Hosted on MSN
Guggenheim raises its price target on Bristol-Myers Squibb Company (BMY) to $72 and reiterates a buy rating
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Most Profitable Undervalued Stocks to Buy On February 6, 2026, Guggenheim raised its price target on Bristol-Myers Squibb Company (NYSE ...
Welcome to Bristol-Myers Squibb Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note today's event is being recorded. I would now like to turn the conference over to Chuck ...
Investors were impressed by the company's performance in the final quarter of 2025. It beat analyst expectations on both the top and bottom lines. Bristol Myers' fourth quarter of 2025 saw the veteran ...
Bristol Myers Squibb (BMY) guided 2026 revenue to $46.0-47.5B, down 3% at midpoint from 2025’s $48.2B. Bristol Myers’ Growth Portfolio surged 16% to $7.4B in Q4 while Legacy Portfolio fell 15% on ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...
Bristol-Myers Squibb (BMY) added ~2% in the premarket on Thursday after the New Jersey-based pharma giant reported better-than-expected Q4 2025 financials and set its 2026 outlook ahead of consensus ...
Bristol Myers Squibb BMY-0.64%decrease; red down pointing triangle reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for ...
Expects 2026 revenue in a range of $46.0 bln-$47.5 bln Lower Eliquis list price will help it avoid US penalties Q4 earnings beat Wall Street expectations on Opdivo strength Feb 5 (Reuters) - (This Feb ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company’s Investor ...
PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — Bristol Myers Squibb Co. (BMY) on Thursday reported fourth-quarter net income of $1.09 billion. The Princeton, New Jersey-based company said it had profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results